Loading...
•
Dec 31, 2025
Conmed Q4 2025 Earnings Report
CONMED Corporation announced its financial results for the fourth quarter and full-year ended December 31, 2025, reporting increased sales and adjusted diluted EPS.
Key Takeaways
CONMED Corporation reported a strong fourth quarter in 2025 with sales increasing by 7.9% year-over-year to $373.2 million and adjusted diluted net earnings per share rising to $1.43. The company highlighted steady execution and progress on operational initiatives, particularly in minimally invasive surgery, smoke evacuation, and orthopedic soft tissue repair.
Fourth quarter 2025 sales reached $373.2 million, marking a 7.9% increase year-over-year.
Adjusted diluted net earnings per share for Q4 2025 were $1.43, up from $1.34 in Q4 2024.
International revenue showed significant growth, increasing by 17.0% as reported and 15.4% in constant currency.
The company's strategic focus remains on key growth drivers: minimally invasive surgery, smoke evacuation, and orthopedic soft tissue repair.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
For the full-year 2026, CONMED expects reported revenue between $1.345 billion and $1.375 billion, representing organic constant currency growth of approximately 4.5% to 6% over 2025 revenue, excluding gastroenterology products. Adjusted diluted net earnings per share are projected to be in the range of $4.30 to $4.45.
Positive Outlook
- Full-year 2026 reported revenue expected between $1.345 billion and $1.375 billion.
- Organic constant currency growth of approximately 4.5% to 6% over 2025 revenue (excluding gastroenterology products).
- Anticipated currency tailwind of approximately 0 to 50 basis points for revenue.
- Adjusted diluted net earnings per share expected in the range of $4.30 to $4.45.
- Includes a currency tailwind of approximately $0.10 for adjusted diluted net earnings per share.
Challenges Ahead
- Exclusion of gastroenterology products from growth calculation for 2026.
- The forward-looking adjusted diluted net earnings per share reconciliation to GAAP is unavailable without unreasonable effort.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...